A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

Clinical trial NCT07321106 · RECRUITING

Trial details

NCT number: NCT07321106
Sponsor: Cartography Biosciences
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Colorectal Cancer (CRC)Colorectal (Colon or Rectal) Cancer CRC Metastatic Colon Cancer Colon Cancer Advanced Colorectal Cancer

Start date: 2026-01-15
Primary completion: 2029-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.